ALAS PROPIAS: Design and Validation of a Questionnaire on Music Therapy and Machista Violence in Intimate Partner Relationships (ALAS PROPIAS)

November 3, 2026 updated by: Eva Maria Leon Zarceño, Universidad Miguel Hernandez de Elche

ALAS PROPIAS Program. Music Therapy, Well-Being and Psychological Health in the Context of Machista Violence in Intimate Partner Relationships: A Triangulation Study

The ALAS PROPIAS Program includes a methodological study to develop and psychometrically validate a structured questionnaire for music therapists. The questionnaire aims to assess music therapists' knowledge, professional competencies, and training needs regarding machista violence in intimate partner relationships, trauma, mental health, and psychological well-being. The study will use a cross-sectional, non-experimental design, with data collected through a self-administered online questionnaire. An expert panel will assess the relevance, clarity, coherence, and pertinence of the questionnaire items. The resulting instrument is intended to help identify training needs and areas for improvement in music therapy practice in this field.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The ALAS PROPIAS Program includes a methodological study aimed at developing and psychometrically validating a structured questionnaire for music therapists. The instrument is designed to assess knowledge, professional competencies, and training needs related to machista violence in intimate partner relationships, trauma, mental health, and psychological well-being.

The study will follow a cross-sectional, non-experimental design, with data collected through a self-administered online questionnaire. The development and validation process will include an expert panel with experience in music therapy, machista violence in intimate partner relationships, trauma and mental health, and research methodology. Experts will assess the relevance, clarity, coherence, and pertinence of the questionnaire items.

The psychometric evaluation will involve music therapists who are currently practising or are in training. The study aims to identify strengths and gaps in professional knowledge and competencies, as well as training needs that may inform improvements in music therapy practice in this field.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.
  • Name: Eva Maria León Zarceño
  • Phone Number: +34 606501888
  • Email: eleon@umh.es

Study Contact Backup

Study Locations

  • Spain
    • Alicante
      • Elche, Alicante, Spain, 03202
        • Universidad Miguel Hernández de Elche
        • Contact:
          • Eva Maria León Zarceño
          • Phone Number: +34 606501888
          • Email: eleon@umh.es
        • Contact:
        • Principal Investigator:
          • Eva Maria León Zarceño
        • Principal Investigator:
          • Vicente Alejandro March Luján
        • Principal Investigator:
          • Marie Laure Rodríguez-Quiroga

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The study population will consist of music therapists in training and music therapists currently practising or recently engaged in professional practice, with no geographical restrictions. Eligible participants must hold a degree in music therapy (bachelor's, master's, or doctoral level) or be currently undertaking music therapy training, have current or recent professional practice, and provide informed consent. The study aims to recruit a minimum of 120 participants for the psychometric analysis of the questionnaire.

Description

Inclusion Criteria:

  1. Holding a degree in music therapy (bachelor's, master's, or doctoral level), or currently undertaking music therapy training.
  2. Current or recent professional practice.
  3. Willingness to participate and provision of informed consent.

Exclusion Criteria:

  • N/A

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: OTHER
  • Time Perspectives: CROSS_SECTIONAL

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Music Therapists and Music Therapy Students

Music therapists currently practising or recently engaged in professional practice, and individuals currently undertaking music therapy training or holding a degree in music therapy (bachelor's, master's, or doctoral level), who meet the study eligibility criteria and provide informed consent. Participants will be recruited nationally and internationally through professional associations, federations, academic networks, and specialised platforms. The planned sample for psychometric analysis is at least 120 participants.
Other: Online Questionnaire Administration

Self-administered online questionnaire used to collect data for the development and psychometric validation of an instrument assessing music therapists' knowledge, professional competencies, and training needs regarding machista violence in intimate partner relationships. This is a data collection procedure, not a therapeutic or clinical intervention.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Development and Psychometric Validation of the Questionnaire for Music Therapists
Time Frame: During questionnaire development and psychometric validation, through anticipated March 2027

Development and psychometric validation of a structured questionnaire designed to assess music therapists' knowledge, professional competencies, and training needs in relation to machista violence in intimate partner relationships, mental health, and psychological well-being.
During questionnaire development and psychometric validation, through anticipated March 2027
Integration of Updated Knowledge on Machista Violence in Intimate Partner Relationships into Music Therapy Practice
Time Frame: During questionnaire development and psychometric validation, through anticipated March 2027

Assessment of the integration of updated knowledge on machista violence in intimate partner relationships into music therapy practice.
During questionnaire development and psychometric validation, through anticipated March 2027
Professional Competencies in Music Therapy Related to Trauma, Emotional Regulation, and Psychological Well-Being
Time Frame: At the time of online questionnaire completion, anticipated March 2027

Assessment of music therapists' professional competencies related to intervention in trauma, emotional regulation, and psychological well-being, as specified in the study objectives.
At the time of online questionnaire completion, anticipated March 2027
Training Factors Associated with Higher Levels of Professional Competence
Time Frame: At the time of online questionnaire completion, anticipated March 2027

Identification of training-related factors associated with higher levels of professional competence among music therapists, based on the information collected through the online questionnaire.
At the time of online questionnaire completion, anticipated March 2027
Areas of Vulnerability and Potential Risks in Clinical Practice Associated with Training Gaps
Time Frame: At the time of online questionnaire completion, anticipated March 2027

Identification of areas of vulnerability or potential risks in music therapy clinical practice associated with possible gaps in professional training regarding machista violence in intimate partner relationships, trauma, and mental health.
At the time of online questionnaire completion, anticipated March 2027
Indicators for Quality Standards in Music Therapy Applied to Machista Violence in Intimate Partner Relationships
Time Frame: By completion of questionnaire data collection and analysis, anticipated 2027

Identification of indicators that may contribute to the development of quality standards for music therapy practice in situations of machista violence in intimate partner relationships, based on the findings of the questionnaire study.
By completion of questionnaire data collection and analysis, anticipated 2027

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Universidad Miguel Hernandez de Elche

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Eva Maria León Zarceño, Universidad Miguel Hernández de Elche.
  • Principal Investigator: Vicente Alejandro March Luján, Catholic University of Valencia
  • Principal Investigator: Marie Laure Rodríguez-Quiroga, Universidad Miguel Hernández de Elche.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 30, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 30, 2027

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 30, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 3, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 3, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
November 9, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
November 9, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 3, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • IDE.DEMLZ.MLRQ.24_3
  • IDE.DEMLZ.MLRQ.24 (Other Identifier: Universidad Miguel Hernández de Elche)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual participant data (IPD) underlying the primary and secondary outcomes will be made available to qualified researchers upon reasonable request submitted to the principal investigator. Data sharing will be subject to ethical review, a formal data-sharing agreement, and strict compliance with European Union GDPR regulations to safeguard minor participants' confidentiality.

IPD Sharing Time Frame

Data will become available after the primary manuscript publishing the final longitudinal findings is accepted

IPD Sharing Access Criteria

Individual participant data will not be publicly shared to protect minor participants' confidentiality in compliance with GDPR and local data protection regulations. Aggregate data and protocol materials are available upon request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings